Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06311383
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2023-12-29
Brief Title:
A Non-interventional Study for Women With HR-positive HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib AIFUL or With Endocrine Therapy or Chemotherapy as First Line Treatment
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis